↓ Skip to main content

Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
2 blogs
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
71 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy
Published in
Therapeutics and Clinical Risk Management, September 2011
DOI 10.2147/tcrm.s11325
Pubmed ID
Authors

Seward Rutkove, McIlduff

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 1%
United States 1 1%
Belgium 1 1%
Canada 1 1%
Unknown 67 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 17%
Student > Master 12 17%
Student > Doctoral Student 6 8%
Student > Bachelor 6 8%
Student > Ph. D. Student 6 8%
Other 17 24%
Unknown 12 17%
Readers by discipline Count As %
Medicine and Dentistry 23 32%
Agricultural and Biological Sciences 11 15%
Pharmacology, Toxicology and Pharmaceutical Science 9 13%
Neuroscience 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 9 13%
Unknown 12 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2022.
All research outputs
#2,107,898
of 22,979,862 outputs
Outputs from Therapeutics and Clinical Risk Management
#93
of 1,271 outputs
Outputs of similar age
#10,589
of 125,672 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 8 outputs
Altmetric has tracked 22,979,862 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,271 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,672 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them